Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Other Non Operating Income (2018 - 2020)

Forte Biosciences (FBRX) has disclosed Other Non Operating Income for 3 consecutive years, with -$83000.0 as the latest value for Q4 2020.

  • On a quarterly basis, Other Non Operating Income fell 103.92% to -$83000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was -$205000.0, a 110.8% decrease, with the full-year FY2024 number at -$190000.0, down 66.67% from a year prior.
  • Other Non Operating Income was -$83000.0 for Q4 2020 at Forte Biosciences, up from -$92000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q4 2019 to a low of -$762000.0 in Q2 2018.
  • A 3-year average of $54181.8 and a median of -$34000.0 in 2018 define the central range for Other Non Operating Income.
  • Peak YoY movement for Other Non Operating Income: surged 99.87% in 2019, then tumbled 1433.33% in 2020.
  • Forte Biosciences' Other Non Operating Income stood at -$301000.0 in 2018, then surged by 803.65% to $2.1 million in 2019, then crashed by 103.92% to -$83000.0 in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Other Non Operating Income are -$83000.0 (Q4 2020), -$92000.0 (Q3 2020), and -$7000.0 (Q2 2020).